Skip to main content

Viral Infection News (Page 7)

FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza

October 24, 2018 – Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

HIV Infection, COVID-19, Herpes Zoster, Influenza, Infections